A biowaiver may be granted to generic immediate release oral solid dosage form products containing BCS Class I active ingredients listed in the Guidance On Biopharmaceutics Classification System (BCS) – Based Biowaiver documents. BCS Based biowaivers takes the three major factors that govern the rate and extent of drug absorption from immediate-release solid dosage forms into account i.e solubility and permeability of the drug substance/ active pharmaceutical ingredient (API), and dissolution characteristics of the drug product. This BCS approach provides an opportunity to waive in vivo pharmacokinetic bioequivalence testing for certain categories of immediate-release drug products.
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Research Article: Der Pharmacia Sinica
Review Article: Der Pharmacia Sinica
Review Article: Der Pharmacia Sinica
Posters & Accepted Abstracts: Der Pharmacia Sinica
Posters & Accepted Abstracts: Der Pharmacia Sinica
Posters & Accepted Abstracts: Der Pharmacia Sinica
Posters & Accepted Abstracts: Der Pharmacia Sinica
ScientificTracks Abstracts: Der Pharmacia Sinica
ScientificTracks Abstracts: Der Pharmacia Sinica
ScientificTracks Abstracts: Der Pharmacia Sinica
ScientificTracks Abstracts: Der Pharmacia Sinica
Keynote: Der Pharmacia Sinica
Keynote: Der Pharmacia Sinica
Der Pharmacia Sinica received 4713 citations as per Google Scholar report